Lillie James Woodruff
Chief Scientific Officer at MPLT
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 3, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MPLTMapLight Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MPLTNo planApr 16, 2026 2026
Sold 4,513 shares at $27.16 ($123k)
Lillie James Woodruff, Chief Scientific Officer
No 10b5-1 planSold 1.5% of holdings ($8.1M position)295,157 shares leftFirst sale on recordFiling
- 2 Form 4 sale MPLTRoutineMay 6, 2026 +20 days
Sold 51,707 shares at $28.40 ($1.5M)
Lillie James Woodruff, Chief Scientific Officer
10b5-1 planSold 17.5% of holdings ($8.4M position)243,450 shares leftFiling
- 3 Form 4 sale MPLTRoutineMay 7, 2026 +1 day
Sold 721 shares at $28.28 ($20k)
Lillie James Woodruff, Chief Scientific Officer
10b5-1 planSold 0.3% of holdings ($6.9M position)242,729 shares leftFiling
- 4 Form 4 sale MPLTUnusualJul 17, 2026 +71 days
Sold 18,267 shares at $36.88 ($674k)
Lillie James Woodruff, Chief Scientific Officer
No 10b5-1 planSold 7.5% of holdings ($9M position)224,462 shares left4x usual sizeFiling
- 5 Form 4 sale MPLTRoutineAug 3, 2026 +17 days
Sold 22,082 shares at $12.54 ($277k)
Lillie James Woodruff, Chief Scientific Officer
10b5-1 planSold 9.8% of holdings ($2.8M position)202,380 shares left1.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Aug 4, 2026 | MPLT | Chief Scientific Officer | Form 4 sale | 22,082 | $277k | 9.8% | Routine | SEC |
| Jul 17, 2026 | Jul 17, 2026 | MPLT | Chief Scientific Officer | Form 4 sale | 18,267 | $674k | 7.5% | Unusual | SEC |
| May 7, 2026 | May 11, 2026 | MPLT | Chief Scientific Officer | Form 4 sale | 721 | $20k | 0.3% | Routine | SEC |
| May 6, 2026 | May 6, 2026 | MPLT | Chief Scientific Officer | Form 4 sale | 51,707 | $1.5M | 17.5% | Routine | SEC |
| Apr 16, 2026 | Apr 17, 2026 | MPLT | Chief Scientific Officer | Form 4 sale | 4,513 | $123k | 1.5% | No plan | SEC |